FRIDAY, Oct. 25, 2024 -- Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective...
Vous n'êtes pas connecté
Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients treated with Ebglyss experienced significant skin clearance as early as...
FRIDAY, Oct. 25, 2024 -- Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective...
FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...
Mesothelioma, a rare and aggressive cancer primarily caused by asbestos exposure, poses significant challenges not only treatment but also in the...
FRIDAY, Nov. 1, 2024 -- Early transcatheter aortic valve replacement (TAVR) is better than clinical surveillance for reducing the incidence of death,...
FRIDAY, Nov. 1, 2024 -- Early transcatheter aortic valve replacement (TAVR) is better than clinical surveillance for reducing the incidence of death,...
Highlights: Skin aging begins as early as your 20s with reduced collagen production Sun protection is the most
THURSDAY, Oct. 31, 2024 -- For patients with asymptomatic severe aortic stenosis and myocardial fibrosis, early aortic valve intervention does not...
Kiwi prostate cancer survivors have wrestled with ED following treatment, as discovered in new findings by the Prostate Cancer Foundation NZ. Kiwis...
Parents of children with atopic dermatitis (eczema) sometimes consider elimination diets to lower food allergy risks. However, a new study reveals...